| Page 1973 | Kisaco Research
 

Gary Sclar

Dana Farber Innovations

Gary Sclar

Dana Farber Innovations

Gary Sclar

Dana Farber Innovations
 

Ronald Dudek

Living Pharma

Ronald Dudek

Living Pharma

Ronald Dudek

Living Pharma
 

James Noble

CEO
Adaptimmune

James Noble

CEO
Adaptimmune

James Noble

CEO
Adaptimmune
 

Karim Helmy

Vice President
Venrock

Karim Helmy

Vice President
Venrock

Karim Helmy

Vice President
Venrock
 

Stefan Jennewein

Managing Director
Jennewein

Dr. Stefan Jennewein studied Biochemistry, Pharmacology and Organic Chemistry at the Universities of Sussex (Brighton, UK), Zurich (CH), Tübingen (D) and Cambridge (UK), and at the Ludwig-Maximilians-Universität (Munich, D), where he obtained a PhD. He also gained practical experience through his work at Washington State University (Pullman, USA), the company DSM N.V. (Delft, NL), the Technical University of Darmstadt (D), and the Fraunhofer Institute for Molecular Biology and Applied Ecology (Aachen, D) as the Head of  the Department of Industrial Biotechnology. Dr.

Stefan Jennewein

Managing Director
Jennewein

Stefan Jennewein

Managing Director
Jennewein

Dr. Stefan Jennewein studied Biochemistry, Pharmacology and Organic Chemistry at the Universities of Sussex (Brighton, UK), Zurich (CH), Tübingen (D) and Cambridge (UK), and at the Ludwig-Maximilians-Universität (Munich, D), where he obtained a PhD. He also gained practical experience through his work at Washington State University (Pullman, USA), the company DSM N.V. (Delft, NL), the Technical University of Darmstadt (D), and the Fraunhofer Institute for Molecular Biology and Applied Ecology (Aachen, D) as the Head of  the Department of Industrial Biotechnology. Dr. Stefan Jennewein is the Founder & CEO of Jennewein Biotechnologie GmbH

How Human Biotechs can Benefit from Collaborations with Animal Health Organizations
 
Animal Health LatAm - Portugues
29-30 May 2018
São Paulo, Brasil
O Fórum de Inovação em Saúde Animal da América Latina regressa em 2018 como continuação das nossas bem-sucedidas séries na Europa e na Ásia. Este evento reúne empresas biotecnológicas em fase de arranque e em fase de crescimento, investidores financeiros e empresas farmacêuticas com vista a estimular mais o crescimento da indústria da saúde animal e o ritmo da inovação através de parcerias e investimentos. O Fórum combina reuniões individuais profícuas e conteúdos educacionais, sessões de pitching (procura de parceiros) e palestras de qualidade sobre as ideias centrais de líderes mundiais. Todas as sessões serão traduzidas em tempo real em espanhol e inglês.